Brief: BioPorto Updates On Decision Regarding FDA Application For Pediatric Clinical Use Of NGAL Test
02/07/2019 11:13
July 2 (Reuters) - Bioporto A/S BIOPOR.CO :
* DECISION REGARDING FDA APPLICATION FOR PEDIATRIC CLINICAL
USE OF
NGAL TEST™ COULD BE EXPECTED BY END-AUGUST 2019/EARLY-SEPTEMBER
2019
Source text for Eikon: ID:nGNE46K07R
Further company coverage: BIOPOR.CO
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))